Prognosis of prostate cancer using color doppler ultrasonography

Salman H Al-Shukri; Anton M Kurnakov; Sergey Yu Borovets

doi:10.17816/uroved616-20

Urology reports (St. - Petersburg) ›› 2016, Vol. 6 ›› Issue (1) :16 -20. DOI: 10.17816/uroved616-20

Articles

research-article

Prognosis of prostate cancer using color doppler ultrasonography

Author information +

History +

PDF (328KB)

Abstract

This comprehensive study analyzes the results of an assessment of 121 patients with an indication for prostate biopsy due to suspected prostate cancer. The color Doppler mapping revealed significant differences in rates of blood circulation in the prostate tumor compared with normal areas. The factor analysis obtained discriminant function which predicted the likelihood of having prostate adenocarcinoma in different zones of multifocal prostate injection punctures. Using collective evaluation of clinical and laboratory factors in determination of individual informative significance related to prostate cancer risk we created mathematical models to optimize multifocal prostate biopsy.

Keywords

prostate cancer / multifocal prostate biopsy / color Doppler mapping

Cite this article

Download citation ▾

Salman H Al-Shukri, Anton M Kurnakov, Sergey Yu Borovets. Prognosis of prostate cancer using color doppler ultrasonography. Urology reports (St. - Petersburg), 2016, 6(1): 16-20 DOI:10.17816/uroved616-20

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Аль-Шукри С.Х., Ткачук В.Н. Опухоли мочеполовых органов. - СПб., 2000. - 309 с.

[2]	Аполихин О.И., Сивков А.В., Москалева Н.Г., и др. Анализ уронефрологической заболеваемости и смертности в Российской Федерации за десятилетний период (2002-2012 гг.) по данным официальной статистики // Экспериментальная и клиническая урология. - 2014. - № 2. - С. 4-12.

[3]	Чиссов В.И., Русаков И.Г. Заболеваемость раком предстательной железы в Российской Федерации // Экспериментальная и клиническая урология. - 2011. - № 2-3. - С. 6-7.

[4]	Cheng L, Jones TD, Pan CX, et al. Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens. Mod Pathol. 2005;18(8):1022-1026. doi: 10.1038/modpathol.3800431.

[5]	Nevoux P, Ouzzane A, Ahmed HU, et al. Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series. BJU Int. 2012; 110(4):517-523. doi: 10.1111/j.1464-410x.2011.10776.x.

[6]	Djavan B, Zlotta A, Remzi M, et al. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol. 2000;163(4):1144-1148. doi: 10.1016/s0022-5347(05)67711-7.

[7]	Sauvain JL, Palascak P, Bourscheid D, et al. Power Doppler and 3D vascular sonography of intraprostatic blood supply: assessment criteria and value for the diagnostic and clinical staging of prostatic cancer. Prog Urol. 2000;10(2):237-245.

[8]

Назаренко Г.И., Хитрова А.Н. Ультразвуковая диагностика предстательной железы в современной урологической практике. - М.: Видар-М, 2012. - С. 121. [Nazarenko GI, Khitrova AN. Ul’trazvukovaya diagnostika predstatel’noi zhelezy v sovremennoi urologicheskoi praktike. Moscow: Vidar-M; 2012. P. 121. (In Russ).]

[9]	Pushkar DY, Govorov AV, Kosko J, et al. Does saturation biopsy reliably predict unilateral prostate cancer in patients with low-risk tumors? Urology. 2007;70(Suppl. 3A):81.

[10]	Scherr DS, Eastham J, Ohori M, Scardino PT. Prostate biopsy techniques and indications: when, where, and how? Semin Urol Oncol. 2002;20(1):18-31.

[11]	Eichler K, Hempel S, Wilby J, et al. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol. 2006;175(5):1605-1612. doi: 10.1016/s0022-5347(05)00957-2.

[12]	Heidenreich A, Bastian PJ, Bellmunt J, et al. European Association of Urology. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014;65(1):24-37.